An artificial intelligence accelerated virtual screening platform for drug discovery
Abstract Structure-based virtual screening is a key tool in early drug discovery, with growing interest in the screening of multi-billion chemical compound libraries. However, the success of virtual screening crucially depends on the accuracy of the binding pose and binding affinity predicted by com...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-09-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-024-52061-7 |